Suchergebnisse - "Bongard, Emily"

PubPharm (5)

1

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness : economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2023

von Li, X. | Bilcke, J. | van der Velden, A. | +51

2

Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries : A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial

enthalten in: Clinical drug investigation | 2021

von Li, X. | Bilcke, J. | van der Velden, A. | +17

3

Oseltamivir for coronavirus illness : post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018

enthalten in: The British journal of general practice : the journal of the Royal College of General Practitioners | 2020

von Coenen, S. | van der Velden, A. | Cianci, D. | +8

4

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care : an open-label, pragmatic, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Butler, C. | van der Velden, A. | Bongard, E. | +32

CommentIn: Lancet. 2020 Jan 4;395(10217):4-6. - PMID 31839278

5

Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E) : the ALIC4 E protocol

enthalten in: BMJ open | 2018

von Bongard, E. | van der Velden, A. | Cook, J. | +30

1
[1]